Background

Iannis is at the forefront of health data science and digital transformation in medicines, with over two decades of expertise in crafting solutions using AI, Natural Language Processing, Real World Evidence, multimodal data integration, and cloud computing. As the director of data science and engineering at leading pharmaceutical companies like Lundbeck and Novo Nordisk, he has been pivotal in seamlessly introducing AI into business processes and part of the AI in medicines discussion with FDA and EMA. Furthermore, Iannis’ contributions to international consortia, notably OHDSI.org (OMOP) and EHDEN.eu, have been instrumental for groundbreaking advancements in health data standardization, precision medicine, and Software as a Medical Device (SaMD) clinical applications. Iannis holds a PhD in Medicine and has published more than 20 scientific papers. Recently, Iannis joined the board of GENerX.life as the Chief AI Officer (CAIO), supporting pharmaceutical organizations across the world tackle AI and Data Science challenges.

Motivation

It feels great to be part of the awesome DDSA initiative. An opportunity to give back to society, and importantly to interact and learn from the brilliant data scientists that participate in the DDSA mentoring program.

Skills, expertise, and interests

• data science
• machine learning
• deep learning
• artificial intelligence
• MLOps
• career planning or change
• big data
• natural language processing (NLP)
• problem solving
• data management
• PhD advice
• causality and explainability
• data mining
• software engineering
• project management
• cloud computing
• leadership
• work-life balance
• time management
• strategy
• health and medical science
• teamwork
• DevOps
• mental health and well-being
• end-to-end implementation
• academic writing skills
• bioinformatics
• pharmaceutics
• life science
• digitalisation
• entrepreneurship and startups
• code review
• version control
• forming sustainable habits
• software project management